FDA UNTITLED_LETTER - Davis City Pharmacy Inc. - February 17, 2022

View on Dashboard

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This UNTITLED LETTER record concerns Davis City Pharmacy Inc., with an inspection on February 17, 2022, issued by the Office of Pharmaceutical Quality, covering drugs.

Company: Davis City Pharmacy Inc.
Inspection Date: February 17, 2022
Product Type: Drugs
Office: Office of Pharmaceutical Quality
People: Dayna Martinez (Senior Compliance Officer)
Shawn E. Larson (Development Coordinator)
Brandi M. Chane-lee

Open in Dashboard

ID · 7aac71cd-7ccf-49e1-9ea2-d38537ed41b1

Violation Codes10

FD&C Act 501(a)(2)(B)21 U.S.C. 331(k)21 U.S.C. 352(f)(1)FD&C Act 301(k)21 U.S.C. 351(a)(2)(B)FD&C Act 505FD&C Act 501(a)(2)(A)FD&C Act 502(f)(1)21 CFR 210.1(b)21 CFR 200.10(b)

Full citation text and observation details available on the Dashboard.